Insight Molecular Diagnostics Inc.
IMDX
$4.01
$0.174.43%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 646.88% | -97.19% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 646.88% | -97.19% | |||
| Cost of Revenue | 382.35% | -97.36% | |||
| Gross Profit | 946.67% | -96.98% | |||
| SG&A Expenses | -11.20% | 16.81% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -9.71% | -53.45% | |||
| Operating Income | 11.74% | 48.30% | |||
| Income Before Tax | -162.47% | 81.31% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -162.47% | 81.31% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -162.47% | 81.31% | |||
| EBIT | 11.74% | 48.30% | |||
| EBITDA | 12.86% | 48.56% | |||
| EPS Basic | -146.50% | 82.64% | |||
| Normalized Basic EPS | 17.37% | -0.11% | |||
| EPS Diluted | -146.50% | 82.64% | |||
| Normalized Diluted EPS | 17.37% | -0.11% | |||
| Average Basic Shares Outstanding | 6.46% | 7.65% | |||
| Average Diluted Shares Outstanding | 6.46% | 7.65% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||